Investor Alert - Cybin: Changing the Mental Healthcare Experience
Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a singl …
On a mission to revolutionize mental healthcare
Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a single-minded goal to dramatically improve patient outcomes versus currently available pharmacotherapies.
Their work includes the development of new drug molecules, with a focus on optimizing treatment outcomes through innovative drug delivery systems, concurrent therapy regimens, and technology-driven patient analytics.
For more information on Cybin Inc. (NEO: CYBN, NYSE AMERICAN: CYBN) please click the request investor info button.
Latest Articles
.png)
Hot Companies
You might also like
CEO Clip - Dakota Gold: Could Richmond Hill Become the Next Gold Mine in South Dakota’s Historic Homestake District?
Dakota Gold is advancing the Richmond Hill Gold Project in South Dakota’s Black Hills, targeting a potentially low-cost mining operation in the historic Homestake Gold District.
U.S. Gold Corp.: Is Wyoming’s CK Gold Project Ready for Mine Construction?
U.S. Gold Corp. is advancing its shovel-ready CK Gold Project in Wyoming, with a completed feasibility study, major permits secured and a focus on developing a new U.S. gold-copper mine.
